Related Articles
CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells
Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome
Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase
Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells